BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma

Community Oncology
doi 10.12788/j.cmonc.0061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontline Medical Communications, Inc.

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy